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Objective: to study the expression and clinical significance CDC20, 
TOP2A, NEK2 esophageal squamous cell carcinoma. Methods: To 
select 70 patients with esophageal squamous cell carcinoma, Between 
August 2018 - August 2020, All intraoperative pathological specimens, 
A group -35 cases), Cancer tissue, B group, adjacent tissues), two groups 
of CDC20, TOP2A, NEK 2 expression were detected and analyzed 
by immunohistochemistry and semi-quantitative reverse transcription 
polymerase chain reaction -RT-PcR) assay.Results: the values of CDC20, 
TOP2A, NEK2 expression level in A group were significantly higher than 
those in B group -P<0.05). The expression level CDC20, TOP2A, NEK2 
esophageal squamous cell carcinoma was positively correlated with TNM 
stage and lymphatic metastasis, and negatively correlated with tumor 
differentiation. Conclusion: CDC20, TOP2A, NEK2 high expression level 
directly affects the metastasis, recurrence and prognosis of esophageal 
squamous cell carcinoma. The combination of three indexes can accurately 
evaluate the pathological status of patients with esophageal squamous cell 
carcinoma and help to judge the prognosis of patients accurately.
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1. Introduction
Esophageal  squamous  ce l l  carc inoma is  a malignant tumor of digestive tract with high clinical incidence. According to the World Health 
Organization report, esophageal squamous cell carcinoma 
in the world ranked eighth, mortality ranked sixth. In our 
country, phase the five-year survival rate in patients with 
esophageal squamous cell carcinoma is between 15% and 
25%, according to the study [1]. With the development of 
modern medical research on the biological mechanism 
and molecular mechanism of esophageal squamous cell 
carcinoma, the gene and protein development mechanism 
related to this disease has made great progress. Related 
studies have confirmed that TOPA2 expression directly 
affects tumor cell apoptosis, while cell division cyclin 20-
CDC20) has a positive effect on tumor cell infiltration. 
Mitotic regulatory kinase 2-NEK2) was significantly 
abnormal in pathological tissues of end-stage tumor 
patients. Expression and clinical significance CDC20, 
TOP2A, NEK2 esophageal squamous cell carcinoma were 
discussed.
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2. Information and Methodology
2.1 General Information
The patients with esophageal squamous cell carcinoma 
were selected from 70 cases of esophageal squamous 
cell carcinoma. The interval was August 2018 - August 
2020. All the samples were collected by intraoperative 
pathology, A group -35 cases, cancer tissue), B group -35 
cases, adjacent tissue).
Among them, Male patients 56, female patients 
24; Between 45 -72, Mean -62.15+2.25) years; TNM 
staging:12 cases in phase I, A total of 33 cases in phase 
II, A total of 23 cases in phase III, Phase IV totalled 
12 cases; Tumor differentiation: a total of 42 cases of 
middle and high differentiation, A total of 38 cases 
of low differentiation; Lymphatic metastasis: a total 
of 33 cases, There were 47 cases without lymphatic 
metastasis. Inclusion criteria:1 all included patients 
did not carry out radiotherapy and chemotherapy 
before operation; -2) indication of surgical resection; 
3. Complete case examination data; Know the contents 
of the test and sign the agreement. Exclusion criteria:1 
with severe complications; Preoperative radiotherapy 
and chemotherapy; 3 Poor coordination. Above data is 
balanced -P>0.05).
2.2 Method
Routine formaldehyde -10% concentration) was used to 
fix all samples. The fixation time was controlled between 
4 -6 h. Gradient dehydration, tissue wax immersion, 
paraffin embedding, sectioning, immunohistochemical S-P 
method were used to observe and evaluate the expression 
gray value of CDC20, TOP2A, NEK2 in esophageal 
squamous cell carcinoma. Results: two experienced 
pathologists were arranged to observe tumor cells, nuclei 
or cytoplasm by high magnification -×400) under the 
condition of double blind method. Once yellow or brown 
granules were found, positive cells could be determined.
Select 5 visual fields for each specimen, And 100 tumor 
cell counts per field of vision, Total 500, The statistical 
ratio of positive cells was calculated accurately. Positive 
criteria: positive cell rate of 10% and above; Negative 
criteria: positive cell rate less than 10%. Semi-quantitative 
reverse transcription polymerase chain reaction -RT-PCR) 
to accurately detect CDc20, TOP2A, NEK2 expression 
factors in the pathological tissue of patients, The 
extraction and DEPC preparation of gene RNA according 
to the standard protocol of the TrizolRNA kit, MRNA 
integrity was identified by agarose gel electrophoresis. 
That is, the practical ABl7500 real-time quantitative PCR 
instrument, Can achieve the purpose of specimen gene 
amplification, After uVIpro ultraviolet gel imaging and 
analysis system observation, scanning, photography and 
other series of operations, The CDC20, TOP2A, NEK2 
and β-actin expression intensity in the picture were 
observed and analyzed.
2.3 Statistical Analysis
The experimental data are processed in parallel SPSS19.0 
new model building, in which the qualitative data are 
expressed as percentage -%) and the test χ is used2The 
quantitative data showed that the results were statistically 
significant P<0.05.
3. Results
3.1 CDC20, TOP2A, NEK2 Expressional Charac-
teristics
S-P results showed that the cancer cells were nest-
like distribution, accompanied by irregular cell series, 
abnormal cells, nuclear mitosis, and obvious positive 
particles in the cytoplasm.
3.2 Analysis of CDC20, TOP2A, NEK2 Expres-
sion in Different Esophageal Tissue Samples
The values of CDC20, TOP2A, NEK2 expression level in 
A group were significantly higher than those in B group 
-P<0.05) (See Table 1).
Table 1. Analysis of CDC20, TOP2A, NEK2 expression in different esophageal tissue samples -±s)
Group CDC20 TOP2A NEK2
mRNA Relative 
Expression Coefficient








The gray level of 
protein expression
A group 1.259±0.246 15.259±4.258 0.668±0.118 54.892±1.976 0.856±0.176 1.235±0.068
B group 0.967±0.168 10.072±4.224 0.516±0.084 42.772±1.617 0.702±0.151 0.865±0.032
t 5.799 5.116 6.208 28.083 3.929 29.127
p 0.000 0.000 0.000 0.000 0.000 0.000
DOI: https://doi.org/10.30564/jor.v2i2.2549
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3.3 CDC20, TOP2A, NEK2 Expression and Clini-
copathological Features and Correlation Analysis
The expression level CDC20, TOP2A, NEK2 esophageal 
squamous cell carcinoma was positively correlated with 
TNM stage and lymphatic metastasis, and negatively 
correlated with tumor differentiation (See Table 2).
4. Discussion
CDC20 cell cyclin plays a key role in the normal mitosis 
of cells, mainly in the  -G stage of cell mitosis2The 
effective regulation of chromosome DNA division and 
replication in M cells and the active promotion of positive 
regulators in late complex / periodic APC/C. Studies 
have confirmed that the occurrence of CDC20 abnormal 
expression is likely to cause mitosis errors, and will lead 
to the wrong expression of some cancer genes and tumor 
suppressor gene mutations or even disappear. Abnormal 
CDC20 expression can create better conditions for the 
proliferation and self-repair of cancer cells, leading to the 
risk of uncontrolled tumor inhibition in cancer patients 
greatly increased [2]. In addition, CDC20 can slow down 
the apoptosis rate of tumor cells and play an important 
role in tumor progression. can be seen that CDC20 
as a new target for tumor therapy is highly feasible. 
According to relevant studies, esophageal squamous 
cell carcinoma is closely related to molecular biological 
factors, including activation / inactivation of proto-cancer 
/ tumor suppressor gene, repair of regulatory DNA and 
dysfunction of regulatory proteins that maintain gene 
stability. TOP2A is an important regulatory enzyme in the 
nucleus, second only to histone protease. Its mechanism 
is to control and change the topological state of DNA 
transcriptional network and the transcription of DNA. It 
has good effect on the function regulation of chromosome 
condensation and chromatid separation [3]. Studies have 
shown that TOPA2 can promote the formation of TOP-
DNA-AMPPNP complexes and participate effectively 
in cell mitosis by shearing DNA,. NEIK2 can establish 
bipolar spindle quickly by regulating the central body 
to copy, separate and mature correctly. At present, it has 
been proved that NEK2 expression is high in many tumors 
and malignant glioma tissues, and with the progression of 
malignant tissues, the expression level of malignant tissues 
increases significantly [4]. Abnormal NEK2 expression is 
highly likely to cause abnormal changes in centrosome 
structure, which in turn leads to functional defects, which 
will lead to the overall stability of infected genes, induce 
malignant transformation of cells and participate in tumor 
metastasis and infiltration.
The results showed that CDC20, TOP2A, NEK2 
and other expression factors in esophageal squamous 
cell carcinoma showed a high level, which showed an 
increasing trend compared with adjacent tissues, and the 
data between groups were significantly different, and 
there was a positive correlation with TNM stage, tumor 
differentiation, lymphatic metastasis and other related 
factors. CDC20, TOP2A, NEK2 directly affects the 
pathological progression and metastasis of esophageal 
squamous cell carcinoma. Therefore, the abnormal 
expression of CDC20, TOP2A, NEK2 is beneficial to 
the prediction and evaluation of invasion, metastasis and 
recurrence of esophageal squamous cell carcinoma, and 
with the aggravation of TNM stage, the expression of 
its indexes is obviously on the rise. By CDC20, TOP2A, 
Table 2. CDC20, TOP2A, NEK2 Expression and clinicopathological features and correlation analysis
Clinical data Number of cases CDC20 positive x2 P TOP2A x2 P NEK2 x2 P
TNM staging 8.903 0.003 6.612 0.010 8.762 0.002
Ⅰ 12 4 (33.33) 3 (25.00) 2 (16.67)
Ⅱ 33 20 (60.61) 19 (57.58) 17 (51.52)
Ⅲ 23 18 (78.26) 18 (78.26) 20 (86.96)
Ⅳ 12 11 (91.67) 10 (83.33) 12 (100.00)
Tumor differentiation 5.038 0.025 6,737 0.009 5.402 0.020
Medium High 
Differentiation 42 28 (66.67) 25 (59.52) 29 (69.05)
Low differentiation 38 32 (84.21) 30 (78.95) 20 (52.63)
lymphatic metastasis 8.202 0.004 4.369 0.037 4.716 0.029
Yes 33 26 (78.79) 24 (72.73) 25 (75.76)
No 47 27 (57.44) 27 (57.44) 28 (49.12)
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NEK2 joint examination, it can provide reliable reference 
for the evaluation of the deterioration and development 
mechanism, stage and differentiation degree of esophageal 
squamous cell carcinoma, and improve the clinical 
diagnosis and treatment effect of esophageal squamous 
cell carcinoma. Combined CDC20, TOP2A, NEK2 
therapy is of great significance for the evaluation of 
pathological status and prognosis of esophageal squamous 
cell carcinoma.
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